Merck (MRK) EBIAT (2016 - 2025)
Historic EBIAT for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $5.8 billion.
- Merck's EBIAT rose 8307.5% to $5.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $19.0 billion, marking a year-over-year increase of 5657.32%. This contributed to the annual value of $17.1 billion for FY2024, which is 444456.23% up from last year.
- Per Merck's latest filing, its EBIAT stood at $5.8 billion for Q3 2025, which was up 8307.5% from $4.4 billion recorded in Q2 2025.
- Over the past 5 years, Merck's EBIAT peaked at $5.8 billion during Q3 2025, and registered a low of -$6.0 billion during Q2 2023.
- For the 5-year period, Merck's EBIAT averaged around $3.2 billion, with its median value being $3.8 billion (2021).
- Per our database at Business Quant, Merck's EBIAT tumbled by 25130.41% in 2023 and then skyrocketed by 40538.34% in 2024.
- Over the past 5 years, Merck's EBIAT (Quarter) stood at $3.8 billion in 2021, then fell by 19.69% to $3.0 billion in 2022, then plummeted by 140.62% to -$1.2 billion in 2023, then soared by 405.38% to $3.7 billion in 2024, then surged by 54.57% to $5.8 billion in 2025.
- Its EBIAT was $5.8 billion in Q3 2025, compared to $4.4 billion in Q2 2025 and $5.1 billion in Q1 2025.